Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
8 NC counties are under alert.
Breaking News
New NC laws on masks, billboards, juvenile justice, campaign finance pass over Cooper vetoes
Program
On WRAL at 6: Are insurance companies watching your home? WRAL's Keely Arthur dives into reports of drones being used to adjust your rates!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
1.070
+0.070 (+7.00%)
Streaming Delayed Price
Updated: 3:03 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
931,122
Open
1.030
Bid (Size)
1.060 (21)
Ask (Size)
1.070 (24)
Prev. Close
1.000
Today's Range
1.015 - 1.100
52wk Range
0.8000 - 2.100
Shares Outstanding
53,309,012
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Expanded Access to XHANCE with Addition to National Commercial Formularies
Today 7:00 EDT
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 17, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Performance
YTD
-14.40%
-14.40%
1 Month
-8.55%
-8.55%
3 Month
-27.70%
-27.70%
6 Month
-21.32%
-21.32%
1 Year
-13.01%
-13.01%
More News
Read More
Why Doximity Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
May 17, 2024
Via
Benzinga
OptiNose's Earnings: A Preview
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
OPTN Stock Earnings: OptiNose Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
May 14, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
May 10, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces $55 Million Registered Direct Offering
May 09, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
April 25, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Are Stocks Down Today?
April 25, 2024
Via
InvestorPlace
Why Is OptiNose (OPTN) Stock Up 12% Today?
April 25, 2024
Via
InvestorPlace
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
April 25, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
Optinose to Present at the Needham Virtual Healthcare Conference
April 04, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024
From
Optinose, Inc.
Via
GlobeNewswire
OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
March 07, 2024
Via
InvestorPlace
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
March 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
February 29, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
January 18, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.